Infections in children and young adults with bone malignancies undergoing limb-sparing surgery

Cancer

Volumn 104, Issue 3, 2005, Pages 602-610

  Gaur, Aditya H ^a   Liu, Tiebin ^a   Knapp, Katherine M ^a   Daw, Najat C ^a,b   Rao, Bhaskar N ^a,b   Neel, Michael D ^a,b   Rodriguez Galindo, Carlos ^a,b   Brand, Diane ^a   Adderson, Elisabeth E ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bacteremia; Bone tumor; Infection; Orthopedic device infection; Prosthetic device infection; Therapy

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AMPUTATION; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BONE CANCER; CANCER SURGERY; CANDIDA ALBICANS; CHILD; CONTROLLED STUDY; DEVICE INFECTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; INFECTION; INFECTION RATE; INFECTION RISK; LIMB SALVAGE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TUMOR LOCALIZATION; WOUND INFECTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; LIMB SALVAGE; MALE; ORTHOPEDIC FIXATION DEVICES; ORTHOPEDICS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; SURVIVAL RATE;

EID: 22544460778     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21212     Document Type: Article

References (22)

1. Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol. 1998;16:2452-2458.
2. Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol. 2003;15:3423-3430.
3. Rao BN, Rodriguez-Galindo C. Local control in childhood extremity sarcomas: salvaging limbs and sparing function. Mod Pediatr Oncol. 2003;41:584-587.
4. Damron TA. Endoprosthetic replacement following limb-sparing resection for bone sarcoma. Semin Surg Oncol. 1997;13:3-10.
5. Refaat Y, Gunnoe J, Hornicek FJ, Mankin HJ. Comparison of quality of life after amputation or limb salvage. Clin Orthop. 2002;397:298-305.
6. Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS. Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study. Arch Phys Med Rehab. 1999;80:615-618.
7. Zalupski MM, Rankin C, Ryan JR, et al. Adjuvant therapy of osterosarcoma - A Phase II trial. Southwest Oncology Group Study 9139. Cancer. 2004;100:818-825.
8. Burdach S, Meyer-Bahlburg A, Laws HJ, et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol. 2003;21:3072-3078.
9. Ozaki T, Hillmann A, Bettin D, Wuisman P, Winkelmann W. High complication rates with pelvic allografts. Experience of 22 sarcoma resections. Acta Orthop Scand. 1996;67:333-338.
10. Sommerville SM, Johnson N, Bryce SL, Journeaux SF, Morgan DA. Contamination of banked femoral head allograft: incidence, bacteriology, and donor follow-up. Aust NZ J Surg. 2000;70:480-484.
11. Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of peroperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA. 2004;291:79-87.
12. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392-1399.
13. Fumary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10:21-33.
14. Araki N, Myoui A, Kuratsu S, et al. Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop. 1999;368:196-206.
15. Bohm P, Springfield R, Springer H. Re-implantation of autoclaved bone segments in musculoskeletal tumor surgery. Clinical experience in 9 patients for 1.1-8.4 years and review of the literature. Arch Orthop Trauma Surg. 1998;118:57-65.
16. Chan YS, Ueng SW, Wang CJ, Lee SS, Chen CY, Shin CH. Antibiotic- impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small infected tibial defects: a comparison study. J Trauma. 2000;48:246-255.
17. Grimer RJ, Belthur M, Carter SR, Tillman RM, Cool P. Extendible replacements of the proximal tibia for bone tumours. J Bone Joint Surg Br. 2000;82:255-260.
18. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother. 2000;46:423-428.
19. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344:11-16.
20. Lesens O, Hansmann Y, Brannigan E, et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect. 2004;48:245-252.
21. Ehrich GD, Hu FZ, Lin Q, Costerton JW, Post JC. Intelligent implants to battle biofilms. ASM News. 2004;70:127-133.
22. Fattom AI, Horwith G, Fuller S, Propst M, Naso R. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to Phase III clinical trials. Vaccine. 2004;22:880-887.